Header Logo

Connection

Alan Landay to Virus Replication

This is a "connection" page, showing publications Alan Landay has written about Virus Replication.
Connection Strength

1.871
  1. Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells. J Infect Dis. 2009 Oct 15; 200(8):1212-5.
    View in: PubMed
    Score: 0.335
  2. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease. AIDS. 2000 May 05; 14(7):761-70.
    View in: PubMed
    Score: 0.174
  3. Induction of HIF-1a by HIV-1 Infection in CD4+ T Cells Promotes Viral Replication and Drives Extracellular Vesicle-Mediated Inflammation. mBio. 2018 09 11; 9(5).
    View in: PubMed
    Score: 0.155
  4. Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production. J Clin Immunol. 1998 Mar; 18(2):124-31.
    View in: PubMed
    Score: 0.149
  5. Inhibition of cytokine-driven human immunodeficiency virus type 1 replication by protease inhibitor. J Infect Dis. 1997 Nov; 176(5):1175-9.
    View in: PubMed
    Score: 0.146
  6. Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression. J Virol. 2017 03 15; 91(6).
    View in: PubMed
    Score: 0.139
  7. Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial. AIDS. 2011 Jun 01; 25(9):1207-17.
    View in: PubMed
    Score: 0.094
  8. Early immune senescence in HIV disease. Curr HIV/AIDS Rep. 2010 Feb; 7(1):4-10.
    View in: PubMed
    Score: 0.085
  9. Interleukin-7 induces HIV replication in primary naive T cells through a nuclear factor of activated T cell (NFAT)-dependent pathway. Virology. 2006 Jul 05; 350(2):443-52.
    View in: PubMed
    Score: 0.065
  10. HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course. J Acquir Immune Defic Syndr. 2003 Dec 15; 34(5):491-6.
    View in: PubMed
    Score: 0.056
  11. Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease. AIDS. 2002 Sep 27; 16(14):1859-66.
    View in: PubMed
    Score: 0.051
  12. Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART. AIDS. 2001 Sep 07; 15(13):1635-41.
    View in: PubMed
    Score: 0.048
  13. CD8+ lymphocytes in pregnancy and HIV infection: characterization of CD8+ subpopulations and CD8+ noncytotoxic antiviral activity. AIDS Res Hum Retroviruses. 1999 May 01; 15(7):665-70.
    View in: PubMed
    Score: 0.041
  14. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J Immunol. 1996 Jan 15; 156(2):841-51.
    View in: PubMed
    Score: 0.032
  15. T. vaginalis Infection Is Associated with Increased IL-8 and TNFr1 Levels but with the Absence of CD38 and HLADR Activation in the Cervix of ESN. PLoS One. 2015; 10(6):e0130146.
    View in: PubMed
    Score: 0.031
  16. Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication. J Clin Invest. 2014 Jun; 124(6):2802-6.
    View in: PubMed
    Score: 0.029
  17. An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol. 1993 Oct; 69(1):106-16.
    View in: PubMed
    Score: 0.028
  18. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol. 2012 07 20; 12(8):607-14.
    View in: PubMed
    Score: 0.025
  19. Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation. AIDS. 1991 Mar; 5(3):269-74.
    View in: PubMed
    Score: 0.023
  20. A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment. J Interferon Cytokine Res. 2011 Jun; 31(6):481-3.
    View in: PubMed
    Score: 0.023
  21. Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture. J Clin Microbiol. 1990 Oct; 28(10):2362-4.
    View in: PubMed
    Score: 0.022
  22. HIV infection of primary CD4+ Th2 cells, defined by expression of the chemoattractant receptor-homologous (CRTH2), induces a Th0 phenotype. AIDS Res Hum Retroviruses. 2007 Feb; 23(2):269-77.
    View in: PubMed
    Score: 0.017
  23. Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function. AIDS. 2004 Mar 05; 18(4):605-13.
    View in: PubMed
    Score: 0.014
  24. Dynamics of cytokine expression in HIV productively infected primary CD4+ T cells. Blood. 2004 Jun 15; 103(12):4581-7.
    View in: PubMed
    Score: 0.014
  25. CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIV. Blood. 2003 Sep 15; 102(6):2156-64.
    View in: PubMed
    Score: 0.013
  26. Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. J Clin Invest. 2001 Feb; 107(3):287-94.
    View in: PubMed
    Score: 0.011
  27. HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication. AIDS. 1999 Jul 09; 13(10):1177-85.
    View in: PubMed
    Score: 0.010
  28. Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers. Infect Control Hosp Epidemiol. 1999 Jun; 20(6):428-30.
    View in: PubMed
    Score: 0.010
  29. Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA. 1998 Jul 01; 280(1):72-7.
    View in: PubMed
    Score: 0.010
  30. HTLV-I activates complement leading to increased binding to complement receptor-positive cells. AIDS Res Hum Retroviruses. 1995 Sep; 11(9):1115-22.
    View in: PubMed
    Score: 0.008
  31. Human immunodeficiency virus (HIV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea-pig sera; activation results in virus neutralization by virolysis. Immunology. 1991 Aug; 73(4):377-82.
    View in: PubMed
    Score: 0.006
  32. Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphotrophic virus-I (HTLV-I) coinfected cells. AIDS Res Hum Retroviruses. 1991 Jul; 7(7):579-85.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.